Abbvie Endocrine Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE INC, and what generic alternatives to ABBVIE ENDOCRINE INC drugs are available?
ABBVIE ENDOCRINE INC has six approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE INC drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE INC drugs in twenty-eight countries.
Summary for Abbvie Endocrine Inc
| International Patents: | 35 |
| US Patents: | 2 |
| Tradenames: | 3 |
| Ingredients: | 1 |
| NDAs: | 6 |
Drugs and US Patents for Abbvie Endocrine Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-008 | Aug 15, 2011 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-006 | Jan 21, 1994 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-007 | Aug 15, 2011 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-009 | Apr 14, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-001 | Oct 22, 1990 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbvie Endocrine Inc
International Patents for Abbvie Endocrine Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 200970600 | ⤷ Subscribe |
| Eurasian Patent Organization | 016176 | ⤷ Subscribe |
| Brazil | PI0720582 | ⤷ Subscribe |
| Israel | 198845 | ⤷ Subscribe |
| Dominican Republic | P2009000144 | ⤷ Subscribe |
| South Korea | 101522035 | ⤷ Subscribe |
| Norway | 20092662 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
